Clinical Trial Update: Combining Doxycycline With Bone-Targeted Therapy in Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating doxycycline in combination with bone-targeted therapy for patients with metastatic breast cancer, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Pain | Phase 2 | Status: COMPLETED